首页 | 本学科首页   官方微博 | 高级检索  
     

力克肺疾与莫西沙星联合治疗耐多药肺结核近期疗效
引用本文:洪梅,郑泽锋,吴捷,翁加豪. 力克肺疾与莫西沙星联合治疗耐多药肺结核近期疗效[J]. 热带医学杂志, 2009, 9(8)
作者姓名:洪梅  郑泽锋  吴捷  翁加豪
作者单位:广东省汕头市第三人民医院,汕头,515073
摘    要:目的评价力克肺疾与莫西沙星联合方案对耐多药肺结核(MDR-TB)的疗效。方法100例MDR-TB患者随机分为两组,每组50例。治疗组用莫西沙星0.4 g/d,力克肺疾1.0 g/d。对照组用左氧氟沙星0.4 g/d,丁胺卡那霉素0.6 g/d,疗程12个月,同时辅以其他抗结核药。结果第3个月末,治疗组痰菌转阴率为74%,明显优于对照组的43%,两组比较差异有统计学意义(P<0.05)。疗程结束时,治疗组痰菌转阴率为96%,明显优于对照组的70%,两组比较差异有统计学意义(P<0.05)。结论以力克肺疾与莫西沙星联合其他抗结核药物组成的化疗方案对MDR-TB疗效肯定,痰菌转阴速度快,值得继续临床探索。

关 键 词:肺结核  耐多药  莫西沙星  力克肺疾  

Curative Effect of Dipasic Combined with Moxifloxacin on Multi-drug Resistant Tubuculosis
HONG Mei,ZHEN Ze-feng,WU Jie,WENG Jia-hao. Curative Effect of Dipasic Combined with Moxifloxacin on Multi-drug Resistant Tubuculosis[J]. Journal Of Tropical Medicine, 2009, 9(8)
Authors:HONG Mei  ZHEN Ze-feng  WU Jie  WENG Jia-hao
Affiliation:The Third People's Hospital of Shantou City;Guangdong;Shantou 515073;China
Abstract:Objective To evaluate the curative effect of dispasic combined with moxifloxacin on multi-drug resistant tubuculosis.Method 100 patients are equally divided into two groups:Patients of therapeutic group treated with moxifloxacin 0.4 / d and another corresponding group treated with Levofloxacin 0.4 g / d,period of patient treatment combined with other assitant pneumonia drug for 12 months.Result By the end of 3rd month,negative ratio of therapeutic group reached 74%,superior to another group which reached 43...
Keywords:pneumonia  tubuculosis  multi-drug resistant  moxifloxacin  dispasic  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号